W. Putten

发表

The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study

J. Foekens, J. Klijn, M. Look, 2004, Breast Cancer Research and Treatment.

Effect of an ACTH(4–9) analogue on cisplatin neuropathy of longstanding duration: a phase II study

C. Vecht, M. Bent, P. Hilkens, 1995, Clinical Neurology and Neurosurgery.

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo

W. van Putten, C. Vecht, A. Hovestadt, 1992, Journal of Neurology.

Complete Sequencing of TP 53 Predicts Poor Response to Systemic Therapy of Advanced Breast Cancer 1

R. Vossen, J. Foekens, J. Klijn, 2000 .

Wound infections after mastectomy or lumpectomy for breast cancer

J. Wereldsma, W. Putten, J. C. Wereldsma, 1997 .

Clinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule

M. Bent, P. Hilkens, J. Moll, 1994, European journal of neurology.

ORG 2766 in the Prevention of Cisplatin Neuropathy

C. Vecht, A. Hovestadt, H. Verbiest, 1991 .

Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer

J. Klijn, J. Verweij, J. Alexieva-Figusch, 1992, Breast Cancer Research and Treatment.

Tumours of the Sympathetic Nervous System

P. Voûte, W. Putten, J. Burgers, 1975 .

Numerical Chromosome 12 Analysis of Carcinoma In Situ and Invasive Germ Cell Tumors of the Adult Testis: A Study Based on the Simultaneous Application of Interphase Cytogenetics and Immunohistochemistry on Tissue Sections

L. Looijenga, A. Gillis, J. Oosterhuis, 1994 .

Acute lymphoblastic leukaemia in adults: Immunological subtypes and clinical features at presentation

G. Ossenkoppele, B. Löwenberg, J. Kluin-Nelemans, 1993, Annals of Hematology.

The somatostatin analog Sandostatin (SMS201-995) in treatment of DMBA-induced rat mammary tumors

J. Foekens, J. Klijn, S. Lamberts, 1990, Breast Cancer Research and Treatment.

Uptake and distribution of doxorubicin in hormone-manipulated human breast cancer cells in vitro

J. Foekens, J. Klijn, A. Sieuwerts, 1998, Breast Cancer Research and Treatment.

Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study)

J. Klijn, J. Alexieva-Figusch, W. Putten, 1985, Medical oncology and tumor pharmacotherapy.

prospective study antigen-alloimmunization and refractoriness: a randomized does not prevent secondary human leukocyte Leukocyte depletion of random single-donor platelet transfusions

F. Claas, K. Sintnicolaas, W. Putten, 2011 .

The influence of the extent of surgery of the neurological function and survival in malignant glioma

C. Avezaat, C. Vecht, W. Eijkenboom, 1990 .

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients.

N. Brünner, J. Foekens, J. Klijn, 2000, Cancer research.

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

H. Putter, T. Bosse, B. van Triest, 2018, British Journal of Cancer.

Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery

C. Avezaat, J. Kros, W. van Putten, 1998, Journal of neurology, neurosurgery, and psychiatry.

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

R. Vossen, J. Foekens, J. Klijn, 2000, Cancer research.

Peripheral neurotoxicity induced by docetaxel

M. J. van den Bent, J. Verweij, W. van Putten, 1996, Neurology.